Author

Angelo Santoro

University of SalernoORCID 0000-0002-9690-907XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Anna Maria D’UrsiiD· 2 shared Carmen MarinoiD· 2 shared Enza NapolitanoiD· 2 shared Manuela GrimaldiiD· 2 shared Michela BuonocoreiD· 2 shared Gaetano BarbatoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Anna Maria D’UrsiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The protective effect of NGF mutant CHF6467 in SH SY5Y cells exposed to Aβ(1-42): a pharmacometabolomic approach

Enza Napolitano, Carmen Marino, Manuela Grimaldi, Michela Buonocore, Angelo Santoro, Gaetano Barbato, Anna Maria D’Ursi

This study uses NMR-metabolomics to show CHF6467 mitigates Aβ(1-42)-induced metabolic changes in SH-SY5Y cells by promoting phospholipid precursors, reducing glutamate excitotoxicity, and restoring energy metabolism.

bioRxiv · Oct 6, 2026 · PreprintCell Biology

Analyzing nicotine action against amyloid toxicity by NMR-pharmacometabolomics: an exploratory study.

Enza Napolitano, Carmen Marino, Manuela Grimaldi, Michela Buonocore, Angelo Santoro, Anna Maria D’Ursi

This study uses NMR-pharmacometabolomics to investigate how nicotine mitigates amyloid toxicity in SH-SY5Y cells, revealing its role in restoring metabolic imbalances linked to Alzheimer's disease.

NMR in Biomedicine · Mar 6, 2026Peer-reviewedCell Biology